187 related articles for article (PubMed ID: 12072192)
41. Vascular cell adhesion molecule 1 induces T-cell antigen receptor-dependent activation of CD4+T lymphocytes.
Damle NK; Aruffo A
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6403-7. PubMed ID: 1713678
[TBL] [Abstract][Full Text] [Related]
42. Induction of linked suppression in addition to the donor H-2 class I-specific unresponsiveness in recipient T cells by transfusing class I plus class II-disparate, but not class I alone-disparate, bone marrow cells.
Muraoka S
Cell Immunol; 1990 Jun; 128(1):261-76. PubMed ID: 1971530
[TBL] [Abstract][Full Text] [Related]
43. Age-related reductions in the activation of mitogen-activated protein kinases p44mapk/ERK1 and p42mapk/ERK2 in human T cells stimulated via ligation of the T cell receptor complex.
Whisler RL; Newhouse YG; Bagenstose SE
Cell Immunol; 1996 Mar; 168(2):201-10. PubMed ID: 8640866
[TBL] [Abstract][Full Text] [Related]
44. Human donor bone marrow cells induce in vitro "suppressor T cells" that functionally suppress autologous B cells.
Carreno MR; Fuller L; Mathew JM; Ciancio G; Burke GW; Esquenazi V; Ricordi C; Tzakis AG; Miller J
Hum Immunol; 2003 Jan; 64(1):21-30. PubMed ID: 12507811
[TBL] [Abstract][Full Text] [Related]
45. Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors.
Shimizu Y; Iwatsuki S; Herberman RB; Whiteside TL
Int J Cancer; 1990 Nov; 46(5):878-83. PubMed ID: 2146230
[TBL] [Abstract][Full Text] [Related]
46. The novel murine CD4+CD8+ thymocyte cell line exhibits lineage commitment into both CD4+ and CD8+ T cells by altering the intensity and the duration of anti-CD3 stimulation in vitro.
Nishida T; Matsuki Y; Ono T; Oguma T; Tsujimoto K; Sato M; Tadakuma T
J Immunol; 2004 Jun; 172(11):6634-41. PubMed ID: 15153478
[TBL] [Abstract][Full Text] [Related]
47. Defective TCR stimulation in anergized type 2 T helper cells correlates with abrogated p56(lck) and ZAP-70 tyrosine kinase activities.
Faith A; Akdis CA; Akdis M; Simon HU; Blaser K
J Immunol; 1997 Jul; 159(1):53-60. PubMed ID: 9200438
[TBL] [Abstract][Full Text] [Related]
48. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.
Matsuda M; Petersson M; Lenkei R; Taupin JL; Magnusson I; Mellstedt H; Anderson P; Kiessling R
Int J Cancer; 1995 Jun; 61(6):765-72. PubMed ID: 7790109
[TBL] [Abstract][Full Text] [Related]
49. CD3-induced T-cell activation in the bone marrow of myeloma patients: major role of CD4+ cells.
Bianchi A; Montacchini L; Barral P; Borrione P; Attisano C; Orsini E; Boccadoro M; Pileri A; Massaia M
Br J Haematol; 1995 Jul; 90(3):625-32. PubMed ID: 7647004
[TBL] [Abstract][Full Text] [Related]
50. In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells.
Woodle ES; Hussein S; Bluestone JA
Transplantation; 1996 Mar; 61(5):798-803. PubMed ID: 8607186
[TBL] [Abstract][Full Text] [Related]
51. Antibody blockade of Thy-1 (CD90) impairs mouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibody.
Haeryfar SM; Conrad DM; Musgrave B; Hoskin DW
Immunol Cell Biol; 2005 Aug; 83(4):352-63. PubMed ID: 16033530
[TBL] [Abstract][Full Text] [Related]
52. Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals.
Metes D; Storkus W; Zeevi A; Patterson K; Logar A; Rowe D; Nalesnik MA; Fung JJ; Rao AS
Transplantation; 2000 Nov; 70(10):1507-15. PubMed ID: 11118098
[TBL] [Abstract][Full Text] [Related]
53. Thy.1lowCD3- cells sorted from nylon wool-passed bone marrow cells can augment the H-2 identical but not non-identical cytotoxic T lymphocyte precursors in mixed lymphocyte cultures.
Mukouyama H; Tanabe MJ
Microbiol Immunol; 1994; 38(12):957-65. PubMed ID: 7723689
[TBL] [Abstract][Full Text] [Related]
54. Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes.
Hegde U; Chhabra A; Chattopadhyay S; Das R; Ray S; Chakraborty NG
Pathobiology; 2008; 75(3):200-8. PubMed ID: 18550918
[TBL] [Abstract][Full Text] [Related]
55. Evidence for protein kinase C-dependent and -independent activation of mitogen-activated protein kinase in T cells: potential role of additional diacylglycerol binding proteins.
Puente LG; Stone JC; Ostergaard HL
J Immunol; 2000 Dec; 165(12):6865-71. PubMed ID: 11120810
[TBL] [Abstract][Full Text] [Related]
56. Human cytotoxic T lymphocytes (CTL) against Epstein-Barr virus (EBV) infected cells: EBV specificity and involvement of major histocompatibility complex determinants in the lysis exerted by anti-EBV CTL toward HLA-compatible and allogeneic target cells.
Lakhdar M; Senik A; Fridman WH
Cell Immunol; 1984 Feb; 83(2):414-21. PubMed ID: 6198104
[TBL] [Abstract][Full Text] [Related]
57. Augmented human-tumor-cytolytic activity of peripheral blood lymphocytes and cells from a mixed lymphocyte/tumor culture activated by interleukin-12 plus interleukin-2, and the phenotypic characterization of the cells in patients with advanced carcinoma.
Koyama S
J Cancer Res Clin Oncol; 1997; 123(9):478-84. PubMed ID: 9341896
[TBL] [Abstract][Full Text] [Related]
58. Age-related impairments in TCR/CD3 activation of ZAP-70 are associated with reduced tyrosine phosphorylations of zeta-chains and p59fyn/p56lck in human T cells.
Whisler RL; Chen M; Liu B; Newhouse YG
Mech Ageing Dev; 1999 Nov; 111(1):49-66. PubMed ID: 10576607
[TBL] [Abstract][Full Text] [Related]
59. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro.
Comoli P; Montagna D; Moretta A; Zecca M; Locatelli F; Maccario R
J Immunol; 1995 Dec; 155(12):5506-11. PubMed ID: 7499831
[TBL] [Abstract][Full Text] [Related]
60. Phosphatidylinositol 3-kinase inhibitors prevent mouse cytotoxic T-cell development in vitro.
Phu T; Haeryfar SM; Musgrave BL; Hoskin DW
J Leukoc Biol; 2001 May; 69(5):803-14. PubMed ID: 11358990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
